MC

Ming Cheah

Board Member at TORL BioTherapeutics

San Francisco Bay Area

Overview

Work Experience

GS

Goldman Sachs

  • Vice President - Life Sciences Investing

    2022 - Current

    Focused on investments in private-stage, emerging therapeutics companies

AT

Ajax Therapeutics

  • Board Member

    2024

AT

Attovia Therapeutics

  • Board Observer

    2024

S

Septerna

  • Board Observer

    2023

TB

TORL BioTherapeutics, LLC

  • Board Observer

    2023

Pb

Pivotal bioVenture Partners

  • Principal

    2020 - 2022

    Investments: Plexium, Exscientia (NAS: EXAI), Vigil Neuro (NAS: VIGL), Obsidian Therapeutics, HotSpot Therapeutics

AP

Avalyn Pharma Inc.

  • Board Observer

    2022 - 2022

P

Plexium

  • Board Observer

    2022 - 2022

HT

HotSpot Therapeutics, Inc.

  • Board Observer

    2021 - 2022

G

Genentech

  • Business Development and Competitive Intelligence

    2016 - 2020

    Led search and evaluation activities for early and clinical stage oncology assets Led teams with direct reports and large cross-functional teams to advise clinical development and commercial strategies for multiple drugs in oncology and neuroscience. Conducted competitive intelligence, market research and forecasting to inform strategic planning.

Education

Relevant Websites